DYNE THERAPEUTICS INC
29.81
06-November-24 15:59:57
15 minutes delayed
Stocks
+1.19
+4.16%
Today's range
29.31 - 30.43
ISIN
N/A
Source
NASDAQ
-
23 Mar 2023 07:30:17 By Nasdaq GlobeNewswire
-
20 Mar 2023 07:30:24 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
07 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
02 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
03 Nov 2022 07:30:01 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Investor Conferences in November
02 Nov 2022 07:30:00 By Nasdaq GlobeNewswire
-
31 Oct 2022 07:30:00 By Nasdaq GlobeNewswire
-
11 Oct 2022 16:10:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
27 Sep 2022 07:30:00 By Nasdaq GlobeNewswire
-
12 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
06 Sep 2022 16:30:00 By Nasdaq GlobeNewswire
-
06 Sep 2022 07:01:00 By Nasdaq GlobeNewswire
-
06 Sep 2022 07:00:01 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Appoints Francesco Bibbiani, M.D., as Senior Vice President, Head of Development
29 Aug 2022 07:30:00 By Nasdaq GlobeNewswire
-
10 Aug 2022 07:30:41 By Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
04 Aug 2022 07:30:01 By Nasdaq GlobeNewswire
-
12 Jul 2022 07:30:00 By Nasdaq GlobeNewswire
-
05 Jul 2022 07:30:00 By Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
03 Jun 2022 07:30:00 By Nasdaq GlobeNewswire